J. Walker

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.

R. Wenham, M. Greene, R. Moser, 2017, Gynecologic oncology.

Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer.

J. Walker, Charlie Gourley, Helen J Mackay, 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

Richard G. Moore, L. Brinton, D. Mutch, 2015, Journal of the National Cancer Institute.

Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.

Joan L. Walker, K. Zorn, D. Mcmeekin, 2008, Gynecologic oncology.

Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study.

T. Grogan, P. Fracasso, M. Brady, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone.

J. Wan, R. Mannel, Joan L. Walker, 2006, Gynecologic oncology.

Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study.

B. Monk, R. Burger, M. Brady, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.

L. Landrum, R. Mannel, K. Moxley, 2022, Gynecologic oncology.

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.

M. Morgan, S. Waggoner, S. Rubin, 2011, Gynecologic oncology.

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

L. Landrum, Joan L. Walker, D. Mcmeekin, 2009, Gynecologic oncology.

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer.

L. Landrum, R. Mannel, Joan L. Walker, 2011, Gynecologic oncology.